FDA approves nivolumab and relatlimab-rmbw for unresectable or metastatic melanoma
On March 18, 2022, the Food and Drug Administration approved nivolumab and relatlimab-rmbw for adult and…
Browsing: FDA Approvals
FDA approves 1st, only immunotherapy-based treatment for use before surgery for non-small cell lung cancer
Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) approved nivolumab 360…